After internalization from the plasma membrane, activated EGF receptors (EGFRs) are delivered to multivesicular bodies (MVBs). Within MVBs, EGFRs are removed from the perimeter membrane to internal vesicles, thereby being sorted from transferrin receptors, which recycle back to the plasma membrane. The phosphatidylinositol (PI) 3′-kinase inhibitor, wortmannin, inhibits internal vesicle formation within MVBs and causes EGFRs to remain in clusters on the perimeter membrane. Microinjection of isotype-specific inhibitory antibodies demonstrates that the PI 3′-kinase required for internal vesicle formation is hVPS34. In the presence of wortmannin, EGFRs continue to be delivered to lysosomes, showing that their removal from the recycling pathway and their delivery to lysosomes does not depend on inward vesiculation. We showed previously that tyrosine kinase-negative EGFRs fail to accumulate on internal vesicles of MVBs but are recycled rather than delivered to lysosomes. Therefore, we conclude that selection of EGFRs for inclusion on internal vesicles requires tyrosine kinase but not PI 3′-kinase activity, whereas vesicle formation requires PI 3′-kinase activity. Finally, in wortmannin-treated cells there is increased EGF-stimulated tyrosine phosphorylation when EGFRs are retained on the perimeter membrane of MVBs. Therefore, we suggest that inward vesiculation is involved directly with attenuating signal transduction.
Skip Nav Destination
Article navigation
24 December 2001
Article|
December 24 2001
Human VPS34 is required for internal vesicle formation within multivesicular endosomes
C.E. Futter,
C.E. Futter
1Institute of Ophthalmology, University College London, London EC1V 9EL, United Kingdom
Search for other works by this author on:
L.M. Collinson,
L.M. Collinson
2Imperial College of Science and Technology, London SW7 2AS, United Kingdom
Search for other works by this author on:
J.M. Backer,
J.M. Backer
3Department of Molecular Pharmacology, Albert Einstein College of Medicine, New York, NY 10461
Search for other works by this author on:
C.R. Hopkins
C.R. Hopkins
2Imperial College of Science and Technology, London SW7 2AS, United Kingdom
Search for other works by this author on:
C.E. Futter
1Institute of Ophthalmology, University College London, London EC1V 9EL, United Kingdom
L.M. Collinson
2Imperial College of Science and Technology, London SW7 2AS, United Kingdom
J.M. Backer
3Department of Molecular Pharmacology, Albert Einstein College of Medicine, New York, NY 10461
C.R. Hopkins
2Imperial College of Science and Technology, London SW7 2AS, United Kingdom
Address correspondence to Colin Hopkins, Dept. of Biochemistry, Imperial College of Science and Technology, London SW7 2AS, UK. Tel.: 44-207-594-5329. Fax: 44-207-225-0960. E-mail: [email protected]
*
Abbreviations used in this paper: EGFR, epidermal growth factor receptor; MVB, multivesicular body; PDGFR, platelet-derived growth factor receptor; PI, phosphatidylinositol; SNX, sorting nexin; TR, transferrin receptor.
Received:
August 31 2001
Revision Received:
October 26 2001
Accepted:
October 29 2001
Online ISSN: 1540-8140
Print ISSN: 0021-9525
The Rockefeller University Press
2001
J Cell Biol (2001) 155 (7): 1251–1264.
Article history
Received:
August 31 2001
Revision Received:
October 26 2001
Accepted:
October 29 2001
Citation
C.E. Futter, L.M. Collinson, J.M. Backer, C.R. Hopkins; Human VPS34 is required for internal vesicle formation within multivesicular endosomes . J Cell Biol 24 December 2001; 155 (7): 1251–1264. doi: https://doi.org/10.1083/jcb.200108152
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionEmail alerts
Advertisement
Advertisement